Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
15 November, 2018 11:19 IST
Lupin gets USFDA nod for generic Tamiflu capsules
Source: IRIS | 10 Jan, 2018, 03.04PM
Comments  |  Post Comment

Pharma Major Lupin announced that it has received final approval for its Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) from the United States Food and Drug Administration (FDA) to market a generic version of Hoffman-La Roche, Inc.'s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg.

Lupin's Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) are the AB rated generic equivalent of Hoffman-La Roche, Inc.'s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg. Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) are indicated for the treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, and prophylaxis of influenza A and B in patients 1 year and older.

Oseltamivir Phosphate Capsules USP, 30 mg, 45 mg, and 75 mg had annual sales of approximately USD 467.8 million in the US. (IMS MAT October 2017).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Zydus receives final approval from the USFDA for Arsenic Trioxide Injection - 15-Nov-2018 10:11
ICICI Bank raises retail term-deposit interest rates by upto 25bps - 15-Nov-2018 09:55
Lupin gets approval for Budesonide inhalation suspension - 13-Nov-2018 13:36
Suven Life Sciences secures 2 overseas product patents - 13-Nov-2018 10:18
GAIL Gas signs MoU with Energy Efficiency Services - 13-Nov-2018 10:14
Lupin launches generic Atovaquone oral suspension in US - 12-Nov-2018 16:06
Zydus Cadila gets USFDAs nod for anti-fungal ointment - 12-Nov-2018 13:40
NHB sanctions Rs 35 bn refinance facility to PNB Housing Finance - 12-Nov-2018 13:17
BHEL commissions 120 MW Pulichintala hydro-electric project - 12-Nov-2018 12:55
Tata Consultancy Services partners with ENGIE Laborelec - 12-Nov-2018 12:52
Lupin gets establishment inspection report for Nagpur unit - 12-Nov-2018 09:56
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer